Exane Derivatives’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,472
| Closed | -$230K | – | 972 |
|
|
2020
Q4 | $230K | Buy |
1,472
+306
| +26% | +$47.8K | 0.07% | 287 |
|
|
2020
Q3 | $133K | Sell |
1,166
-66
| -5% | -$7.55K | 0.04% | 237 |
|
|
2020
Q2 | $138K | Sell |
1,232
-4,928
| -80% | -$553K | 0.04% | 231 |
|
|
2020
Q1 | $553K | Buy |
6,160
+4,961
| +414% | +$445K | 0.15% | 103 |
|
|
2019
Q4 | $135K | Sell |
1,199
-1,003
| -46% | -$113K | 0.03% | 278 |
|
|
2019
Q3 | $216K | Buy |
2,202
+1,300
| +144% | +$127K | 0.04% | 235 |
|
|
2019
Q2 | $118K | Buy |
+902
| New | +$118K | 0.02% | 300 |
|
|
2019
Q1 | – | Sell |
-24
| Closed | -$2.34K | – | 681 |
|
|
2018
Q4 | $2.34K | Hold |
24
| – | – | ﹤0.01% | 480 |
|
|
2018
Q3 | $3.36K | Sell |
24
-980
| -98% | -$137K | ﹤0.01% | 435 |
|
|
2018
Q2 | $125K | Sell |
1,004
-151
| -13% | -$18.9K | 0.02% | 283 |
|
|
2018
Q1 | $127K | Buy |
1,155
+736
| +176% | +$80.9K | 0.03% | 260 |
|
|
2017
Q4 | $50.1K | Buy |
419
+137
| +49% | +$16.4K | 0.01% | 302 |
|
|
2017
Q3 | $39.6K | Buy |
+282
| New | +$39.6K | 0.01% | 294 |
|
|
2015
Q1 | – | Sell |
-254
| Closed | -$47K | – | 511 |
|
|
2014
Q4 | $47K | Buy |
+254
| New | +$47K | 0.01% | 287 |
|